Walvax Biotechnology Co., Ltd. (SHE: 300142)

Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 20.92 billion as of December 20, 2024. Its market cap has decreased by -44.83% in one year.

• Market Cap: 20.92B
• Enterprise Value: 20.16B
• Revenue: 3.10B
• Ranking: n/a
• PE Ratio: 170.95
• Stock Price: 13.03

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 20.92B, an increase of 53.42%. That is a compound annual growth rate of 3.08%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	20.92B	-44.36%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	49.87B	69.84%